BCL2L11 and acute lymphoblastic leukemia: This is in line with another study which showed that T-acute lymp hoblastic leukemia (T-ALL) cells acquire resistance to dex-mediated killing through abnormal activation of Akt, resulting in inhibition of the FoxO3a/Bim pathway [44].